Skip to main navigation Skip to search Skip to main content

Central nervous system stimulants and drugs that suppress appetite

  • Lise Aagaard*
  • *Corresponding author for this work

Research output: Chapter in Book/Report/Conference proceedingBook chapterResearchpeer-review

Abstract

The Side Effects of Drugs Annuals form a series of volumes in which the adverse effects of drugs and adverse reactions to them are surveyed. The series supplements the contents of Meyler's Side Effects of Drugs: the International Encyclopedia of Adverse Drug Reactions and Interactions. This review of the January 2012 to June 2013 publications on central nervous system stimulants and drugs that suppress appetite covers amphetamines (including metamfetamine, paramethoxyamfetamine and paramethoxymetamfetamine), fenfluramine and benfluorex, atomoxetine, methylphenidate, modafinil and armodafinil, methylxanthines (caffeine and theophylline), drugs that suppress appetite (phentermine, rimonabant, and sibutramine) and drugs used in Alzheimer's disease (donepezil and rivastigmine).

Original languageEnglish
Title of host publicationA worldwide yearly survey of new data in adverse drug reactions
EditorsSidhartha D. Ray
PublisherElsevier
Publication date2014
Pages1-9
ISBN (Electronic)978-0-444-63407-8
DOIs
Publication statusPublished - 2014
SeriesSide Effects of Drugs Annual
Volume36
ISSN0378-6080

Keywords

  • Adverse reactions
  • Alzheimer's disease
  • Amfetamine
  • Amphetamines
  • Appetite suppressants
  • Armodafinil
  • Atomoxetine
  • Benfluorex
  • Caffeine
  • Dexamfetamine
  • Donepezil
  • Fenfluramine
  • Galantamine
  • Metamfetamine
  • Methylphenidate
  • Methylxanthines
  • Modafinil
  • Paramethoxyamfetamine
  • Paramethoxymetamfetamine
  • Phentermine
  • Rimonabant
  • Rivastigmine
  • Sibutramine
  • Theophylline

Fingerprint

Dive into the research topics of 'Central nervous system stimulants and drugs that suppress appetite'. Together they form a unique fingerprint.

Cite this